---
figid: PMC4671844__jgo-06-06-660-f2
figtitle: MAPK signaling pathway in CRC
organisms:
- NA
pmcid: PMC4671844
filename: jgo-06-06-660-f2.jpg
figlink: /pmc/articles/PMC4671844/figure/f2/
number: F2
caption: MAPK signaling pathway in CRC. Mutations in KRAS and BRAF result in constitutive
  activation of the signaling cascade resulting in uninhibited cellular proliferation
  and tumor growth. These effects occur downstream of the EGFR receptor, rendering
  this mutant tumors resistant to anti EGFR therapies. CRC, colorectal cancer; EGFR,
  epidermal growth factor receptor; MEK, mitogen-activated protein kinase
papertitle: 'BRAF mutant colorectal cancer as a distinct subset of colorectal cancer:
  clinical characteristics, clinical behavior, and response to targeted therapies.'
reftext: Callisia N. Clarke, et al. J Gastrointest Oncol. 2015 Dec;6(6):660-667.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9585422
figid_alias: PMC4671844__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4671844__F2
ndex: 03459fa3-deb6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4671844__jgo-06-06-660-f2.html
  '@type': Dataset
  description: MAPK signaling pathway in CRC. Mutations in KRAS and BRAF result in
    constitutive activation of the signaling cascade resulting in uninhibited cellular
    proliferation and tumor growth. These effects occur downstream of the EGFR receptor,
    rendering this mutant tumors resistant to anti EGFR therapies. CRC, colorectal
    cancer; EGFR, epidermal growth factor receptor; MEK, mitogen-activated protein
    kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
